DNLI EPS Estimates
Denali Therapeutics Inc.
$17.87
-$0.53(-2.88%)
39
Overall
60
Value
18
Tech
39
Quality
Market Cap
$2.86B
Volume
2.70M
52W Range
$13.75 - $27.30
Target Price
$35.41
DNLI EPS estimates: the consensus estimate for Denali Therapeutics Inc.'s current fiscal year is -$2.67 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DNLI EPS Estimates
- EPS estimate, current quarter
- $-0.67
- EPS estimate, next quarter
- $-0.63
- EPS estimate, current year
- $-2.67
- EPS estimate, next year
- $-2.43
- EPS growth, 3-year
- -4.53%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.97 |
| 2024 | $-2.57 |
| 2023 | $-1.06 |
| 2022 | $-2.60 |
| 2021 | $-2.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $17.87 | -2.9% | 2.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW